Martin, Monica L.
Bitzer, Alexis A.
Schrader, Andrew
Bergmann-Leitner, Elke S.
Soto, Kim
Zou, Xiaoyan
Beck, Zoltan
Matyas, Gary R.
Dutta, Sheetij
Funding for this research was provided by:
United States Agency for International Development (Inter-Agency Agreement)
Department of Defence
Article History
Received: 29 August 2019
Accepted: 18 November 2019
First Online: 27 November 2019
Ethics approval and consent to participate
: Research was conducted under an IACUC-approved animal use protocol in a AAALAC International accredited facility in compliance with the Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals and adheres to principles stated in the eighth edition, Guide for the Care and Use of Laboratory Animals, NRC Publication, 2011 edition.
: Material has been reviewed by the Walter Reed Army Institute of Research and the US Agency for Internationals Development. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official, or as reflecting true views of the Department of the Army, the Department of Defense, or the US Agency for International Development.
: SD has a patent on the FMP013. ZB, SD and GRM have filed patents on the ALFQ formulation of FMP013.